Gu, Yisu
Bartolomé-Casado, Raquel http://orcid.org/0000-0002-8966-9047
Xu, Chuan http://orcid.org/0000-0002-6265-999X
Bertocchi, Alice http://orcid.org/0000-0003-0909-2434
Janney, Alina http://orcid.org/0000-0002-0024-2603
Heuberger, Cornelia
Pearson, Claire F. http://orcid.org/0000-0001-5816-1657
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Thornton, Emily E. http://orcid.org/0000-0002-0068-2502
Powrie, Fiona http://orcid.org/0000-0003-3312-5929
Article History
Received: 26 August 2022
Accepted: 28 February 2024
First Online: 3 April 2024
Competing interests
: C.H. is a current employee of F. Hoffmann-La Roche. S.A.T. is a remunerated member of the scientific advisory board of Element Biosciences, Foresite Labs and Qiagen. S.A.T. is co-founder and equity holder of Transition Bio and EnsoCell, as well as a part-time employee of GlaxoSmithKline. F.P. receives consultancy fees or research support from Janssen, GSK, Genentech, and T-Cypher. The other authors declare no competing interests.